Preferred Label : Chronic Lymphocytic Leukemia;
NCIt synonyms : B Cell Chronic Lymphocytic Leukemia; B-Cell Chronic Lymphocytic Leukemia; Chronic B-Cell Lymphocytic Leukemia; Hematopoeitic - Chronic Lymphocytic Leukemia (CLL); B Cell CLL; B-Cell Lymphocytic Leukemia; B Cell Lymphocytic Leukemia; B-Cell Chronic Lymphoid Leukemia; B-Cell CLL; BCLL;
NCIt related terms : Chronic Lymphocytic Leukemia (CLL); Chronic lymphatic leukemia; CLL; Chronic lymphocytic leukemia, NOS;
NCIt definition : The most common type of chronic lymphoid leukemia. It comprises 90% of chronic lymphoid
leukemias in the United States. Morphologically, the neoplastic cells are small, round
B-lymphocytes. This type of leukemia is not considered to be curable with available
therapy. (WHO, 2001);
Alternative definition : NCI-GLOSS: An indolent (slow-growing) cancer in which too many immature lymphocytes
(white blood cells) are found mostly in the blood and bone marrow. Sometimes, in later
stages of the disease, cancer cells are found in the lymph nodes and the disease is
called small lymphocytic lymphoma.;
Neoplastic status : Malignant;
Codes from synonyms : CDR0000346545; CDR0000044846; 10008960;
Origin ID : C3163;
UMLS CUI : C0023434;
Automatic exact mappings (from CISMeF team)
Currated CISMeF NLP mapping
DO Cross reference
Disease excludes abnormal cell
Disease excludes normal cell origin
Disease may have findings
False automatic mappings
Has associated anatomic sites
Semantic type(s)
UMLS correspondences (same concept)
Validated automatic mappings to BTNT
associated_with_malfunction_of_gene_product
concept_is_in_subset
disease_excludes_finding
disease_has_abnormal_cell
disease_has_accepted_treatment_with_regimen
disease_has_associated_disease
disease_has_associated_gene
disease_has_finding
disease_has_molecular_abnormality
disease_has_normal_cell_origin
disease_has_normal_tissue_origin
disease_has_primary_anatomic_site
https://www.has-sante.fr/jcms/p_3536003/fr/sequencage-haut-debit-cible-d-un-panel-de-genes-dans-la-prise-en-charge-medicale-de-la-leucemie-lymphoide-chronique-rapport-d-evaluation
2024
France
health technology assessment
leukemia, lymphocytic, chronic, B-Cell
IPSS-R Risk Category High
Physical Examination
Has_Target
NCI CTEP SDC Chronic Lymphoid Leukemia Sub-Category Terminology
albumin/globulin ratio
Target
evaluation report
patient care management
sequence analysis
Panel Device
leukemia, lymphoid
Output
High Level
Assessment
Target Lesion Identification
genes
leukaemia
Topical Dosage Form
Assessment
sequence determinations
chronic lymphocytic leukemia
IPSS Risk Category High
High Mitosis-Karyorrhexis Index
Topical Route of Administration
Evaluation
Charge
Ratio
Backflow
Chronic Lymphocytic Leukemia
High-Frequency Microsatellite Instability
Regulatory Report
Value Above Reference Range
evaluation studies as topic
Nucleic Acid Sequencing
---
https://www.cochrane.org/fr/CD013474/HAEMATOL_le-traitement-dentretien-apres-un-traitement-anterieur-est-il-plus-efficace-que-lobservation-ou-le
2024
United Kingdom
review of literature
french abstract
adulthood
Legal Adult
NCI CTEP SDC Chronic Lymphoid Leukemia Sub-Category Terminology
What Month is it
Observation
Illinois
Treatment Compliance
leukemia, lymphoid
Interleukin
leukaemia
Observation Study Epoch
adult
interviews as topic
Until Effective
chronic lymphocytic leukemia
leukemia, lymphocytic, chronic, B-Cell
Chronic Lymphocytic Leukemia
placebos
Prior Therapy
Maintenance Therapy
patient compliance
interview
Israel
Post-Therapy
---